Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains

✍ Scribed by Thomas M. File; Javier Garau; Michael R. Jacobs; Brian Wynne; Monique Twynholm; Elchonon Berkowitz

• Book ID: 119259048
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 176 KB
• Volume: 25
• Category: Article
• ISSN: 0924-8579
• DOI: 10.1016/j.ijantimicag.2004.10.007